Mr. Speaker, the pharmaceutical industry is the main sector of biomedical research in Canada, accounting for more than $561 million in R and D investments in 1994. It is, moreover, one of the few healthy sectors of the Montreal economy. According to a number of sources, however, the government appears to be preparing to modify the link regulations under Bill C-91.
Will the Minister of Industry confirm that his government is preparing to modify regulations relating to Bill C-91 on the pharmaceutical industry in such as way as to greatly reduce the protection of drug patents?